Cargando…

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway

Anti-angiogenic therapy is one of the promising strategies for many types of solid cancers. Bevacizumab (Avastin), a recombinant humanized monoclonal antibody of vascular endothelial growth factor (VEGF) A, was approved for the first time as an anti-angiogenic drug for the treatment of metastatic co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itatani, Yoshiro, Kawada, Kenji, Yamamoto, Takamasa, Sakai, Yoshiharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979390/ https://www.ncbi.nlm.nih.gov/pubmed/29670046 http://dx.doi.org/10.3390/ijms19041232

Ejemplares similares

Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
por: Itatani, Yoshiro, et al.
Publicado: (2019)

Treatment of Elderly Patients with Colorectal Cancer
por: Itatani, Yoshiro, et al.
Publicado: (2018)

The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
por: Itatani, Yoshiro, et al.
Publicado: (2016)

Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer
por: Itatani, Yoshiro, et al.
Publicado: (2020)

The Role of Tumor-Associated Neutrophils in Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
por: Toda, Kosuke, et al.
Publicado: (2017)

Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer
por: Yamamoto, Takehito, et al.
Publicado: (2021)

Robot-assisted low anterior resection after aluminum potassium sulfate and tannic acid sclerosing therapy for internal hemorrhoids
por: Itatani, Yoshiro, et al.
Publicado: (2019)

Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
por: Haibe, Yolla, et al.
Publicado: (2020)

Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5
por: Nishikawa, Gen, et al.
Publicado: (2019)

The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
por: Carter, James G., et al.
Publicado: (2014)

Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2
por: Kakizaki, Fumihiko, et al.
Publicado: (2016)

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
por: Guyot, Mélanie, et al.
Publicado: (2016)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013)

Anti-angiogenic therapy for ovarian cancer
por: García García, Yolanda, et al.
Publicado: (2020)

Anti-VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles
por: Munster, Michal, et al.
Publicado: (2014)

Anti-Angiogenic Effect of Asperchalasine A Via Attenuation of VEGF Signaling
por: Park, Jun Yeon, et al.
Publicado: (2019)

Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
por: Stratman, Amber N., et al.
Publicado: (2020)

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
por: van Beijnum, Judy R., et al.
Publicado: (2022)

Laparoscopic distal gastrectomy for gastric cancer patient with intestinal malrotation: report of a case
por: Inamoto, Susumu, et al.
Publicado: (2019)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

F-Box/WD Repeat Domain-Containing 7 Induces Chemotherapy Resistance in Colorectal Cancer Stem Cells
por: Honma, Shusaku, et al.
Publicado: (2019)

Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020)

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013)

Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale
por: Harris, Sheila, et al.
Publicado: (2012)

Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
por: Bourhis, Morgane, et al.
Publicado: (2021)

Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
por: Cao, Mengyuan, et al.
Publicado: (2022)

Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)

Future options of anti-angiogenic cancer therapy
por: Cao, Yihai
Publicado: (2016)

Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
por: Ichikawa, Kenji, et al.
Publicado: (2020)

Correlation between Colon Perfusion and Postoperative Fecal Output through a Transanal Drainage Tube during Laparoscopic Low Anterior Resection
por: Kawada, Kenji, et al.
Publicado: (2022)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s669v679edqn901rrgctha9851